• Profile
Close

Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients

Nephrology Dialysis Transplantation Apr 14, 2020

Crépin T, Legendre M, Carron C, et al. - Researchers assessed immune senescence at different chronic kidney disease (CKD) stages as well as its impact on CKD patient outcomes in this longitudinal prospective analysis. They obtained data from 222 patients at different CKD stages [1–2 (n = 85), 4 (n = 53) and 5 (n = 84)]. CKD was identified to be related to a rise in immune senescence as well as inflammation biomarkers, as follows: low thymic output, a raised proportion of terminally differentiated T cells restricted to cytomegalovirus-positive patients, telomere shortening and a rise in C-reactive protein levels. A link of shorter relative telomere length (RTL) with death was revealed in multivariate analysis. Overall, the link of CKD with premature immune ageing was evident. Experts noted that each of these changes raised the risk of particular age-associated diseases, such as RTL and death, thymic function and infections and terminally differentiated CD8+ T-cell expansion and cardiovascular events. .

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay